News

Eli Lilly: 50% Upside For LLY Stock?
In the wake of this sell-off, a critical question arises about whether LLY stock represents a buying opportunity.
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
The stock is struggling badly, and if things don't improve in short order, Eli Lilly will be on track for its worst ...
Lilly pill cuts body weight by 12.4% in trial, lagging Novo's Wegovy injection
Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage ...
Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down
Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...
Stocks to Watch Recap: Eli Lilly, Firefly, DoorDash, TSMC
The iPhone maker's shares [rallied for a second day]( ...
S&P 500 eases with Eli Lilly; Nasdaq manages record closing high
The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...
Benzinga.com6h
Eli Lilly's Orforglipron Data Is Not Disastrous: Analyst
Orforglipron cut weight by 12.4% vs. 0.9% with placebo, below 15% expectations. BofA lowered Eli Lilly's price forecast to ...
Eli Lilly (LLY) Sees Revenue Surge With Innovative Treatments And Raised Earnings Guidance
Eli Lilly (LLY) has recently launched SenderraCare+, a digital solution paired with its biologic treatment EBGLYSS, and announced positive outcomes from a Phase 3 trial for the weight management drug ...